Dow Chemical is paying more than $15 billion for Rohm and Haas, a maker of specialty chemical products. Alisa Roth has more details about the deal and why Dow considers it "game-changing" for the company.
The Food and Drug Administration is expected to recommend stronger warnings today about epilepsy drugs and the risk of suicide for people who take them. These drugs are big sellers, with $10 billion in sales last year. John Dimsdale reports.
French energy company has decided not to invest in a project to develop natural gas fields in Iran. Renita Jablonski talks to Financial Times Chief Energy Correspondent Carola Hoyos about what kind of message this sends.
There are roughly 13 million 19 to 29-year-olds in the U.S. without health insurance, and insurance companies are trying to reach out to them through hip marketing. But Devin Dwyer reports many of them will still say no.
Employers hired workers in May at the slowest pace in about five years, but the unemployment hasn't moved that much. Scott Jagow talks to economics correspondent Chris Farrell, who doesn't get the job numbers.
European labor unions are angry with the Pentagon for tearing up a huge contract with plane maker Airbus. Stephen Beard reports the U.S. government broke the $35 billion deal so a Seattle company could bid.